AIM ImmunoTech Stock Forum

$AIM ImmunoTech (AIM.US)$
AIM ImmunoTech Announces NYSE American Acceptance of Plan to Regain Listing Compliance
Wednesday, 26th February at 1:20 pm
OCALA, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: AIM) ("AIM" or the "Company") today announced that it received notice from the NYSE American (the "American") that the American has accepted the Company's Plan to regain compliance with the minimum stockholders' equity requirements of Sections 1003(a)(ii) and 1003(a)(iii) o...

$AIM ImmunoTech (AIM.US)$
👀

$AIM ImmunoTech (AIM.US)$ looking ready 😍

$AIM ImmunoTech (AIM.US)$
extracted from X, NFA
Our lead program is an immuno-modulator that has shown positive data published in
numerous well-respected journals and forums. Learn more: bit.ly/4gzyqnz

$AIM ImmunoTech (AIM.US)$ with few potential news, yet it still haven't rise yet lol

$AIM ImmunoTech (AIM.US)$ ok i loaded the boat

$AIM ImmunoTech (AIM.US)$ Reuters· 1 min ago
AIM ImmunoTech Announces That It Will Not Proceed With an Offering Pursuant to Its Registration Statement on Form S-1 Until After It Files Its Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2024

$AIM ImmunoTech (AIM.US)$
4X Immune Response: AIM's Ampligen Breakthrough with AstraZeneca's FluMist Against Bird Flu

$AIM ImmunoTech (AIM.US)$
AIM ImmunoTech announces a planned follow-up clinical study evaluating a combination treatment of AIM's Ampligen® and AstraZeneca's FluMist® to address the recent avian influenza outbreaks
Friday, 7th February at 8:50 am
OCALA, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: AIM) ("AIM" or the "Company") today announced its initiation of a plan to advance Ampligen as a vaccine adjuvant for avian influenza as part of the Company's antiviral priorit...

$AIM ImmunoTech (AIM.US)$ might heat up today